| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.54▼ | 1.53▼ | 1.53▼ | 1.50▼ | 1.45▲ |
| MA10 | 1.54▼ | 1.56▼ | 1.56▼ | 1.49▲ | 1.60▼ |
| MA20 | 1.56▼ | 1.55▼ | 1.53▼ | 1.45▲ | 1.83▼ |
| MA50 | 1.52▼ | 1.51▼ | 1.49▲ | 1.60▼ | 1.95▼ |
| MA100 | 1.49▲ | 1.46▲ | 1.46▲ | 1.81▼ | 1.18▲ |
| MA200 | 1.45▲ | 1.49▲ | 1.59▼ | 1.95▼ | 1.38▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.010▼ | -0.008▼ | 0.025▲ | -0.056▼ |
| RSI | 37.543▼ | 42.603▼ | 45.515▼ | 48.623▼ | 44.804▼ |
| STOCH | 15.278▼ | 15.278▼ | 13.492▼ | 61.694 | 14.353▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -36.667 | -82.569▼ |
| CCI | -180.633▼ | -194.622▼ | -214.380▼ | 75.253 | -54.820 |
|
Saturday, April 04, 2026 09:23 PM
NEW YORK, April 03, 2026 (GLOBE NEWSWIRE)-- IN8bio, Inc. (the “Company”) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative γδ T cell therapies for cancer and autoimmune ...
|
|
Monday, February 09, 2026 11:37 AM
I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be IN8bio (INAB). The reason why I want to go over this biotech next is because it reported ...
|
|
Monday, February 09, 2026 05:00 AM
NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- IN8bio (INAB) (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ ) T cell therapies and T cell engagers for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/04/26 | 1.54 | 1.555 | 1.50 | 1.50 | 92,104 |
| 28/04/26 | 1.5249 | 1.59 | 1.52 | 1.53 | 52,623 |
| 27/04/26 | 1.48 | 1.61 | 1.48 | 1.56 | 131,085 |
| 24/04/26 | 1.42 | 1.50 | 1.41 | 1.50 | 46,752 |
| 23/04/26 | 1.50 | 1.5489 | 1.41 | 1.42 | 46,143 |
| 22/04/26 | 1.55 | 1.55 | 1.48 | 1.50 | 51,550 |
| 21/04/26 | 1.56 | 1.59 | 1.4501 | 1.48 | 116,768 |
| 20/04/26 | 1.46 | 1.50 | 1.44 | 1.50 | 73,524 |
| 17/04/26 | 1.4603 | 1.465 | 1.42 | 1.44 | 18,586 |
| 16/04/26 | 1.42 | 1.48 | 1.3688 | 1.45 | 89,380 |
|
|
||||
|
|
||||
|
|